MedTrace Logo

To Evaluate the Adhesion of TK-254RX on Healthy Participants

NCT07307794 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-01-28

No results posted yet for this study

Summary

This study is a single-center, open-label, multiple-dose trial in healthy participants. The primary purpose of this study is to assess the adhesion of TK-254RX. Secondary purposes are to assess the safety of TK-254RX and the residual amount of the patch.

Conditions

  • Healthy Participants

Interventions

DRUG

Esflurbiprofen Topical System

The total of one TK-254RX per day for 3 days

Sponsors & Collaborators

  • SocraTec R&D GmbH

    collaborator OTHER

  • SocraMetrics GmbH

    collaborator INDUSTRY

  • HWI pharma services GmbH

    collaborator INDUSTRY

  • Clinsearch GmbH

    collaborator UNKNOWN

  • CRM Biometrics GmbH

    collaborator INDUSTRY

  • Teikoku Seiyaku Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Kenichi Nishiyama · Teikoku Seiyaku Co., Ltd.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-19
Primary Completion
2026-03-31
Completion
2026-03-31
FDA Drug
Yes

Countries

  • Germany

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07307794 on ClinicalTrials.gov